Lina Life Partners with Anticancer Therapy Research Association to Develop Cancer Insurance

Lina Life Insurance announced on the 9th that it has signed a Memorandum of Understanding (MOU) with the Korean Association for Cancer Chemotherapy to promote public health improvement through cancer clinical research and treatment.

[Asia Economy Reporter Oh Hyung-gil] LINA Life Insurance announced on the 9th that it has signed a Memorandum of Understanding (MOU) with the Korean Association for Cancer Chemotherapy to promote public health improvement through cancer clinical research and treatment.

LINA Life Insurance plans to incorporate cancer treatment technologies and specialized medical information provided by the Korean Association for Cancer Chemotherapy into its product development. Additionally, it will engage in various activities such as producing content to provide accurate health information related to cancer and hosting cancer-related symposiums.

Last December, LINA Life Insurance launched a special rider focusing on targeted cancer treatment, securing exclusive usage rights for six months.

Hong Bong-seong, President of LINA Life Insurance, stated, "We have always strived to develop products from the customer's perspective and provide services that care for customers' health beyond insurance," adding, "We hope this collaboration will serve as an opportunity to solidify LINA Life Insurance's reputation as a leading cancer insurance provider."

This content was produced with the assistance of AI translation services.